Micciche', Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1.403
EU - Europa 1.323
AS - Asia 383
AF - Africa 5
OC - Oceania 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.120
Nazione #
US - Stati Uniti d'America 1.345
DE - Germania 596
CN - Cina 221
SE - Svezia 192
IT - Italia 155
UA - Ucraina 123
FR - Francia 60
CA - Canada 58
GB - Regno Unito 57
SG - Singapore 55
IN - India 43
IE - Irlanda 42
ID - Indonesia 27
BE - Belgio 25
TR - Turchia 25
FI - Finlandia 24
RU - Federazione Russa 15
AT - Austria 11
JP - Giappone 9
CZ - Repubblica Ceca 7
CI - Costa d'Avorio 5
AU - Australia 3
NL - Olanda 3
NO - Norvegia 3
CH - Svizzera 2
CL - Cile 2
ES - Italia 2
IR - Iran 2
RO - Romania 2
BD - Bangladesh 1
DK - Danimarca 1
EU - Europa 1
MD - Moldavia 1
MK - Macedonia 1
RS - Serbia 1
Totale 3.120
Città #
Chandler 310
Ann Arbor 140
Jacksonville 93
Ashburn 79
Nanjing 52
San Mateo 52
Houston 47
Dearborn 43
Woodbridge 43
Dublin 42
Nürnberg 39
New York 29
Singapore 29
Cattolica 27
Jakarta 27
Milan 26
Bremen 25
Brussels 25
Marseille 23
Munich 23
Wilmington 23
Lawrence 22
Los Angeles 22
Nanchang 22
Izmir 21
North York 21
Zhengzhou 20
Toronto 19
Boardman 18
Fairfield 17
Boston 15
Beijing 13
Seattle 13
Enterprise 12
Ottawa 12
Kunming 11
Moscow 11
Pune 11
Redwood City 11
Shenyang 11
Rome 10
Shanghai 10
Vienna 10
Mountain View 8
Changsha 7
Hebei 7
Redmond 7
Tianjin 7
Detroit 6
Jiaxing 6
Leawood 6
Abidjan 5
Augusta 5
Chicago 5
Fremont 5
Guangzhou 5
Monmouth Junction 5
Norwalk 5
Princeton 5
Sassari 5
University Park 5
Bareggio 4
Columbus 4
Haikou 4
Hangzhou 4
Lancaster 4
Cosenza 3
Jinan 3
Lanzhou 3
Phoenix 3
San Francisco 3
San Jose 3
Simi Valley 3
Tokyo 3
Washington 3
Apricena 2
Bern 2
Bucharest 2
Costa Mesa 2
Halle 2
Hefei 2
Helsinki 2
Kocaeli 2
Monopoli 2
Montreal 2
Montréal 2
Ningbo 2
Paris 2
Saint Petersburg 2
Selargius 2
Stockholm 2
Taizhou 2
Aci Catena 1
Amsterdam 1
Atlanta 1
Auburn Hills 1
Barcelona 1
Belgrade 1
Berlin 1
Bologna 1
Totale 1.722
Nome #
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 236
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 207
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 187
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population 175
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 175
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 167
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 160
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 131
Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases 117
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 116
Multiple abscesses in a patient treated with cetuximab 116
Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis 109
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 108
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 105
HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region 105
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 104
Adverse skin reactions during treatment with cetuximab plus radiotherapy: Multidisciplinary approach to minimize radio-chemotherapy interruption 96
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 93
Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma 88
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 84
Modelling tumour volume variations in head and neck cancer: magnetic resonance imaging contribution for patients undergoing induction chemotherapy 80
Oncologic outcome of hypopharyngeal carcinoma treated with different modalities at 2 different university hospitals 79
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 76
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 76
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 67
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 59
Osteoradionecrosis of the jaws due to teeth extractions during and after radiotherapy: A systematic review 45
Totale 3.161
Categoria #
all - tutte 9.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.726


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020401 0 0 39 25 56 52 56 27 44 28 44 30
2020/2021294 21 37 33 27 34 15 26 6 31 10 44 10
2021/2022380 40 26 8 39 12 21 9 48 17 22 60 78
2022/2023766 101 124 74 130 48 79 37 46 83 4 28 12
2023/2024287 18 70 8 20 13 50 6 32 7 7 28 28
2024/202586 15 31 40 0 0 0 0 0 0 0 0 0
Totale 3.161